We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Conference

ESGO State of the Art 2018 Conference

October 4-6, 2018 · Lyon, France

soaconference.esgo.org

176 submissions

QUALITY INDICATORS (QIs) IN RARE OVARIAN CANCER MANAGEMENT SUGGEST A REGIONAL-LEVEL ORGANISATION

GCT

stromal

borderline

Mullerian adenosarcoma: a clinicopathologic and management review of 5 cases

adenosarcoma

mullerian tumors

Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors

Use of the Poly(ADP-Ribose) Polymerase Inhibitor Rucaparib in Women with Recurrent Ovarian Carcinoma with Endometrioid and Other Nonserous Histopathologic Subtypes

Tumor treating fields (200 kHz) with weekly paclitaxel for recurrent ovarian cancer in the INNOVATE Phase 2 study: Final results

Syringoid eccrine carcinoma of the vulva: differential diagnosis, treatment and follow-up.

syringoid eccrine carcinoma

Prognosis factors in malignant ovarian germ cell tumors (MOGCT): retrospective analysis of 147 cases prospectively included in the French network for Rare Malignant Ovarian Tumors (TMRO) & GINECO group

Rare case report of Primary Pseudomyxoma ovarii with disseminated peritoneal adenomucinosis

disseminated peritoneal adenomucinosis .

Significance of PET-CT as the preoperative evaluation in endometrial cancer

pet-ct

endometrial caner

Outcome of subsequent pregnancy after chemotherapy for high risk gestational trophoblastic neoplasia: a case report

gestational trophoblastic neoplasia

A wound that failed to heal: high-grade ovarian serous carcinoma associated with chronic Schistosomiasis

schistosomiasis

ovarian serous carcinoma

Comprehensive molecular profiling of adult ovarian granulosa cell tumors (GCT) identifies candidate actionable targets

granulosa cell tumors

Management of borderline ovarian tumors in women younger than 45 years

borderline ovarian tumor

fertility

Comparison between PET CT and AGO score for operability evaluation in recurrent ovarian cancer: a retrospective study

recurrent ovarien carcinoma

pet ct

Immunohistochemical analysis of Nidogen I expression in epithelial ovarian cancer tissues in comparison to normal ovarian tissues - preliminary findings.

ovarian cancer

nidogen i

nidogen

PPARgamma Activation and XIAP Inhibition Mutually Augment their respective Anticancer Effects in Granulosa Cell Tumors of the Ovary

granulosa cell tumor

combination therapy

The mutational and copy number landscape of ovarian carcinosarcoma

carcinosarcoma

carcinoma

sarcoma

tp53

FBXW7 mutations in serous endometrial cancers cause increased levels of potentially druggable proteins and in vitro sensitivity to SI-2 and dinaciclib

fbxw7

serous endometrial cancer

mutation

Is Clearance of HPV related to infection with Chlamydia and Ureaplasma after conization?

hpv

chlamydia

cervical conization

Primary bilateral squamous cell carcinoma of the fallopian tube: a case report

fallopian tube

The driver mutational landscape of ovarian squamous cell carcinomas arising in mature cystic teratoma

ovarian

scc

mct

bi-allelic tp53

OVARIAN GRANULOSA CELL TUMORS: A RETROSPECTIVE STUDY OF 14 CASES

ovarian granulosa cell tumor

diagnosis

Clinical Approaches and Outcomes of Serous Endometrial Cancer in a Large Tertiary Referral Centre

serous

endometrial cancer

radiotherapy

CLINICAL APPLICATION OF WHOLE EXOME SEQUENCING IN A CASE OF METASTASISED LOW GRADE SEROUS OVARIAN CANCER

braf

low grade ovarian cancer

genomics

1 2 3 4 5 6 7 8

Company

Legal

Home About Contact

Imprint Terms of Service Privacy Policy